Clinithink
PrivateLast Round
Growth Equity
May 8, 2023
Est. Valuation
$50M
Total Funding Raised
$10M
Company Overview
Clinithink operates in Healthcare & Life Sciences and is based in Alpharetta, Georgia. Its latest recorded funding round was a Growth Equity round in May 2023.
Clinithink is a healthcare technology company that provides an AI-powered platform to transform unstructured clinical narrative from medical records into structured, actionable data for healthcare and life sciences organizations.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, NLP & Conversational AI, Clinical Trials, Medical AI, Revenue Cycle
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Clinithink Comparables
Compare Clinithink with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Savana | 87% | |
| emtelligent | 85% | |
| LynxCare | 85% |
For institutional investors. Book with your work email.
Clinithink Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | May 8, 2023 | ||||
| Series D | Jan 7, 2019 | ||||
| Series C | Jul 1, 2017 | ||||
| VC Round | Jun 30, 2014 | ||||
| Series A | Jul 29, 2012 |
For institutional investors. Book with your work email.
Clinithink Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Merck Global Health Innovation Fund | Growth Equity |
| Vanguard Atlantic | Series D, Series A, Series C, VC Round |
| Truehelm | Series D, Growth Equity |
| Development Bank of Wales | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 21, 2026
Monthly visitors increased 53% MoM.
- May 1, 2025
Monthly visitors increased 61% MoM.
For institutional investors. Book with your work email.
Clinithink Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Clinithink's valuation, stock price, and market status.
Is Clinithink a public or private company?
Clinithink is a private company.
What is the current stock price of Clinithink?
Clinithink is a private company, so its shares have no public market price. Caplight tracks Clinithink's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Clinithink worth (valuation)?
Clinithink's valuation is estimated at $50.0M based on funding round data.
Can I buy Clinithink stock?
Clinithink shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Clinithink's last funding round?
Clinithink's most recent funding round was Growth Equity on May 8, 2023.
Who are the main investors in Clinithink?
Key investors in Clinithink include Merck Global Health Innovation Fund, Vanguard Atlantic, Truehelm.
Will Clinithink IPO soon?
No public IPO plans have been announced for Clinithink.
How can I track Clinithink secondary market activity?
Caplight tracks bids, offers, and trades in Clinithink's shares on secondary markets.